Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Lemtrada
Sanofi MS drug nears green light after pass-the-parcel marathon
Sanofi MS drug nears green light after pass-the-parcel marathon
Reuters
Europe
Lemtrada
MS
multiple sclerosis
Sanofi
Sanofi’s Lemtrada MS Drug Effective in Extension Trial
Sanofi’s Lemtrada MS Drug Effective in Extension Trial
Bloomberg
Lemtrada
MS
multiple sclerosis
Sanofi
Sanofi says FDA starts review of new MS drug Lemtrada; decision due in late 2013
Sanofi says FDA starts review of new MS drug Lemtrada; decision due in late 2013
Yahoo/AP
FDA
Lemtrada
MS
multiple sclerosis
Sanofi
Sanofi draws fire over cost of MS drug Lemtrada
Sanofi draws fire over cost of MS drug Lemtrada
Reuters
Lemtrada
MS
multiple sclerosis
Sanofi
Sanofi Aims to Add Second-Generation Lemtrada to Pipeline
Sanofi Aims to Add Second-Generation Lemtrada to Pipeline
Bloomberg
Genzyme
Lemtrada
MS
multiple sclerosis
Sanofi
Sanofi signals Lemtrada confidence with CVR buyback
Sanofi signals Lemtrada confidence with CVR buyback
Reuters
CVRs
Lemtrada
MS
multiple sclerosis
Sanofi
Sanofi Receives FDA Refusal To File for Lemtrada, Pushes Back Launch Potential
Sanofi Receives FDA Refusal To File for Lemtrada, Pushes Back Launch Potential
Yahoo/Reuters
FDA
Genzyme
Lemtrada
Sanofi
Sanofi pulls leukemia drug ahead of possible OK for Lemtrada
Sanofi pulls leukemia drug ahead of possible OK for Lemtrada
Reuters
Campath
Lemtrada
leukemia
Sanofi
Genzyme seeks approvals for MS drug
Genzyme seeks approvals for MS drug
Boston Globe, MA
Genzyme
Lemtrada
MS
multiple sclerosis
Sanofi
Genzyme moves potential MS therapy closer to FDA finish line with positive Phase 3 data
Genzyme moves potential MS therapy closer to FDA finish line with positive Phase 3 data
Bizjournals.com
FDA
Genzyme
Lemtrada
MS
multiple sclerosis
1
2
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT